hexafluorenium has been researched along with Kidney Failure, Chronic in 1 studies
hexafluorenium: curarimimetic agent for use with succinylcholine; muscle relaxant; structure; RN given refers to parent cpd
Kidney Failure, Chronic: The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Radnay, PA | 1 |
| El-Gaweet, ES | 1 |
| Novakovic, M | 1 |
| Badola, R | 1 |
| Cizmar, S | 1 |
| Duncalf, D | 1 |
1 other study available for hexafluorenium and Kidney Failure, Chronic
| Article | Year |
|---|---|
Prevention of succinylcholine induced hyperkalemia by neurolept anesthesia and hexafluorenium in anephric patients.
Topics: Adult; Anesthesia; Female; Fluorenes; Hexamethonium Compounds; Humans; Hyperkalemia; Kidney Failure, | 1981 |